{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:09:48Z","timestamp":1790104188817,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:00:00Z","timestamp":1518220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.coviro.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T20:03:02Z","timestamp":1519243382000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Recent advances in viral vectors in veterinary vaccinology"],"prefix":"10.1016","volume":"29","author":[{"given":"Michael D","family":".Baron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venugopal","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2018.02.002_sbref0005","series-title":"Conquering the Cattle Plague: International Food Policy Research Institute Discussion Paper","first-page":"923","author":"Roeder","year":"2009"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0010","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1099\/jgv.0.000944","article-title":"Future research to underpin successful peste des petits ruminants virus (PPRV) eradication","volume":"98","author":"Baron","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0015","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.4049\/jimmunol.1502625","article-title":"The opportunity to eradicate peste des petits ruminants","volume":"196","author":"Mariner","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.coviro.2018.02.002_sbref0025","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.gt.3302618","article-title":"Use of adenoviral vectors as veterinary vaccines","volume":"12","author":"Ferreira","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040686","article-title":"Future prospects for the development of cost-effective adenovirus vaccines","volume":"18","author":"Fougeroux","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2018.02.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2016.06.001","article-title":"Viral vectors as vaccine carriers","volume":"21","author":"Ertl","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0040","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1128\/JVI.77.24.13407-13411.2003","article-title":"Detailed analysis of the CD8+ T-cell response following adenovirus vaccination","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-1656(00)00314-X","article-title":"Adenoviruses as vectors for delivering vaccines to mucosal surfaces","volume":"83","author":"Babiuk","year":"2000","journal-title":"J Biotechnol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0050","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5011","article-title":"Construction and characterization of adenovirus vectors","author":"Ross","year":"2009","journal-title":"Cold Spring Harb Protocols"},{"key":"10.1016\/j.coviro.2018.02.002_bib0055","first-page":"193","article-title":"Production and formulation of adenovirus vectors","volume":"99","author":"Altaras","year":"2005","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0060","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/biot.201400390","article-title":"Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials","volume":"10","author":"Kallel","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.coviro.2018.02.002_bib0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-679-5_13","article-title":"Scalable production of adenovirus vectors","volume":"1089","author":"Silva","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0070","doi-asserted-by":"crossref","first-page":"e67888","DOI":"10.1371\/journal.pone.0067888","article-title":"Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice","volume":"8","author":"Pearson","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2018.02.002_bib0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2016.04.067","article-title":"Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying","volume":"506","author":"LeClair","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coviro.2018.02.002_bib0080","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.vaccine.2016.03.061","article-title":"Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle","volume":"34","author":"Dulal","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_bib0085","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1038\/ncomms13520","article-title":"Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months","volume":"7","author":"Pelliccia","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2018.02.002_bib0090","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0095","doi-asserted-by":"crossref","first-page":"20617","DOI":"10.1038\/srep20617","article-title":"Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever","volume":"6","author":"Warimwe","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2018.02.002_bib0100","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children","volume":"24","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_bib0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.virol.2013.12.029","article-title":"Protection of non-human primates against rabies with an adenovirus recombinant vaccine","volume":"450\u2013451","author":"Xiang","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.02.002_bib0110","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(02)00344-4","article-title":"Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge","volume":"20","author":"Fischer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_bib0115","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0264-410X(99)00545-9","article-title":"Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies","volume":"18","author":"Monteil","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_bib0120","series-title":"Global Control and Eradication of Peste Des Petits Ruminants","author":"FAO, OIE","year":"2015"},{"key":"10.1016\/j.coviro.2018.02.002_bib0125","doi-asserted-by":"crossref","first-page":"e101226","DOI":"10.1371\/journal.pone.0101226","article-title":"Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep","volume":"9","author":"Rojas","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2018.02.002_bib0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1297-9716-45-24","article-title":"Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR","volume":"45","author":"Herbert","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.coviro.2018.02.002_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13567-016-0306-4","article-title":"Determination of the minimum fully protective dose of adenovirus-based DIVA vaccine against peste des petits ruminants virus challenge in East African goats","volume":"47","author":"Holzer","year":"2016","journal-title":"Vet Res"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0140","series-title":"Diseases of Poultry","author":"Swayne","year":"2013"},{"key":"10.1016\/j.coviro.2018.02.002_bib0145","article-title":"Hatchery vaccination against poultry viral diseases: potential mechanisms and limitations","author":"Abdul-Cader","year":"2017","journal-title":"Viral Immunol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0150","series-title":"Update on Avian Influenza in Animals (Types H5 and H7)","author":"OIE","year":"2017"},{"key":"10.1016\/j.coviro.2018.02.002_bib0155","article-title":"Avian influenza overview October 2016\u2013August 2017","volume":"15","author":"Brown","year":"2017","journal-title":"EFSA J"},{"key":"10.1016\/j.coviro.2018.02.002_bib0160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.20506\/rst.30.3.2081","article-title":"Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination","volume":"30","author":"Swayne","year":"2011","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.coviro.2018.02.002_bib0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1743-422X-9-294","article-title":"Isolation of avian influenza H5N1 virus from vaccinated commercial layer flock in Egypt","volume":"9","author":"El-Zoghby","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2018.02.002_bib0170","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1016\/j.vaccine.2011.08.115","article-title":"Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/viro.1995.1430","article-title":"Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens","volume":"211","author":"Darteil","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0180","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1128\/JVI.75.23.11868-11873.2001","article-title":"Recombinant Newcastle disease virus as a vaccine vector","volume":"75","author":"Nakaya","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0185","doi-asserted-by":"crossref","first-page":"10054","DOI":"10.1128\/JVI.78.18.10054-10063.2004","article-title":"A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV","volume":"78","author":"Huang","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0190","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1073\/pnas.0602566103","article-title":"Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease","volume":"103","author":"Park","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2018.02.002_bib0195","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0264-410X(99)00369-2","article-title":"Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert","volume":"18","author":"Swayne","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0168-1702(88)90075-5","article-title":"Construction of recombinant fowlpox viruses as vectors for poultry vaccines","volume":"10","author":"Boyle","year":"1988","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2018.02.002_bib0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1373.023","article-title":"Development and use of fowlpox vectored vaccines for avian influenza","volume":"1081","author":"Bublot","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coviro.2018.02.002_bib0210","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.vaccine.2003.10.039","article-title":"Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens","volume":"22","author":"Francois","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_bib0215","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1099\/vir.0.19570-0","article-title":"Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague","volume":"84","author":"Veits","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0220","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/S0264-410X(01)00167-0","article-title":"Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene","volume":"19","author":"Luschow","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_bib0225","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/viro.1999.9641","article-title":"Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2","volume":"257","author":"Tsukamoto","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.02.002_bib0230","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0264-410X(97)80001-1","article-title":"Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1","volume":"16","author":"Sakaguchi","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_bib0235","doi-asserted-by":"crossref","first-page":"39263","DOI":"10.1038\/srep39263","article-title":"Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2018.02.002_bib0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1637\/8735-032509-Reg.1","article-title":"Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels","volume":"54","author":"Sarfati-Mizrahi","year":"2010","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_bib0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/03079457.2010.541226","article-title":"Maternal immunity against avian influenza H5N1 in chickens: limited protection and interference with vaccine efficacy","volume":"40","author":"Maas","year":"2011","journal-title":"Avian Pathol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0250","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1637\/8908-043009-Reg.1","article-title":"Passive protection afforded by maternally-derived antibodies in chickens and the antibodies\u2019 interference with the protection elicited by avian influenza inactivated vaccines in progeny","volume":"54","author":"De Vriese","year":"2010","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_bib0255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.vetimm.2013.01.006","article-title":"Passive antibody transfer in chickens to model maternal antibody after avian influenza vaccination","volume":"152","author":"Faulkner","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0260","doi-asserted-by":"crossref","first-page":"858","DOI":"10.2307\/1591544","article-title":"Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein","volume":"36","author":"Morgan","year":"1992","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_bib0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1128\/JVI.75.2.971-978.2001","article-title":"The genome of turkey herpesvirus","volume":"75","author":"Afonso","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0270","author":"Swayne","year":"2013"},{"key":"10.1016\/j.coviro.2018.02.002_bib0275","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2307\/1588488","article-title":"Protection against Marek's disease by vaccination with a herpesvirus of turkeys","volume":"14","author":"Okazaki","year":"1970","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_bib0280","unstructured":"Merial: VAXXITEK\u00ae HVT+ IBD. http:\/\/www.merial.ca\/en\/poultry\/productslivevaccines\/Pages\/vaxxitek.aspx."},{"key":"10.1016\/j.coviro.2018.02.002_bib0285","unstructured":"Ceva: Vectormune\u00ae. https:\/\/www.vectormune.com\/."},{"key":"10.1016\/j.coviro.2018.02.002_bib0290","unstructured":"MSD: INNOVAX\u00ae. https:\/\/www.innovax-vaccines.com\/."},{"key":"10.1016\/j.coviro.2018.02.002_bib0295","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1099\/vir.0.81498-0","article-title":"Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease","volume":"87","author":"Baigent","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0300","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3382\/ps.2013-03249","article-title":"Decay of maternal antibodies in broiler chickens","volume":"92","author":"Gharaibeh","year":"2013","journal-title":"Poult Sci"},{"key":"10.1016\/j.coviro.2018.02.002_bib0305","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/bioe.20476","article-title":"Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpesvirus of turkeys as vector","volume":"3","author":"Iqbal","year":"2012","journal-title":"Bioengineered"},{"key":"10.1016\/j.coviro.2018.02.002_bib0310","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1637\/11267-090115-Reg","article-title":"Vaccine protection of turkeys against H5N1 highly pathogenic avian influenza virus with a recombinant turkey herpesvirus expressing the hemagglutinin gene of avian influenza","volume":"60","author":"Kapczynski","year":"2016","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156747","article-title":"Protective efficacy of recombinant turkey herpes virus (rHVT-H5) and inactivated H5N1 vaccines in commercial mulard ducks against the highly pathogenic avian influenza (HPAI) H5N1 Clade 2.2.1 virus","volume":"11","author":"Kilany","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2018.02.002_bib0320","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1637\/11129-050715-Reg","article-title":"Recombinant turkey herpesvirus-AI vaccine virus replication in different species of waterfowl","volume":"60","author":"Palya","year":"2016","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_bib0325","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1637\/10172-041012-Reg.1","article-title":"Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian Clade 2.2.1 HPAI H5N1 strains","volume":"56","author":"Rauw","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0330","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0335","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21645515.2015.1012013","article-title":"Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades","volume":"11","author":"Crevar","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.coviro.2018.02.002_bib0340","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01581-17","article-title":"Computationally optimized broadly reactive hemagglutinin elicits hemagglutination inhibition antibodies against a panel of H3N2 influenza virus cocirculating variants","volume":"91","author":"Wong","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0345","doi-asserted-by":"crossref","DOI":"10.1145\/2818302","article-title":"Construction of recombinant HVT expressing PmpD, and immunological evaluation against Chlamydia psittaci and Marek's disease virus","volume":"10","author":"Liu","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0350","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.vaccine.2017.12.025","article-title":"A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR\/Cas9 system","volume":"36","author":"Tang","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.002_sbref0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jviromet.2009.01.009","article-title":"Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions","volume":"158","author":"Petherbridge","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.coviro.2018.02.002_bib0360","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1637\/11359-122615-RegR","article-title":"Combination of two Marek's disease virus vectors shows effective vaccination against Marek's disease, infectious bursal disease, and Newcastle disease","volume":"60","author":"Ishihara","year":"2016","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2018.02.002_bib0365","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1128\/JVI.77.16.9084-9089.2003","article-title":"Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism","volume":"77","author":"Casais","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0370","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1128\/JVI.78.24.13804-13811.2004","article-title":"Recombinant infectious bronchitis coronavirus Beaudette with the spike protein gene of the pathogenic M41 strain remains attenuated but induces protective immunity","volume":"78","author":"Hodgson","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.002_bib0375","doi-asserted-by":"crossref","first-page":"e24352","DOI":"10.1371\/journal.pone.0024352","article-title":"A recombinant avian infectious bronchitis virus expressing a heterologous spike gene belonging to the 4\/91 serotype","volume":"6","author":"Armesto","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625718300178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625718300178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T02:37:10Z","timestamp":1565318230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625718300178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":75,"alternative-id":["S1879625718300178"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2018.02.002","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in viral vectors in veterinary vaccinology","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}